Literature DB >> 27512058

Graf1 Controls the Growth of Human Parainfluenza Virus Type 2 through Inactivation of RhoA Signaling.

Keisuke Ohta1, Hideo Goto1, Yusuke Matsumoto1, Natsuko Yumine1, Masato Tsurudome2, Machiko Nishio3.   

Abstract

UNLABELLED: Rho GTPases are involved in a variety of cellular activities and are regulated by guanine nucleotide exchange factors and GTPase-activating proteins (GAPs). We found that the activation of Rho GTPases by lysophosphatidic acid promotes the growth of human parainfluenza virus type 2 (hPIV-2). Furthermore, hPIV-2 infection causes activation of RhoA, a Rho GTPase. We hypothesized that Graf1 (also known as ARHGAP26), a GAP, regulates hPIV-2 growth by controlling RhoA signaling. Immunofluorescence analysis showed that hPIV-2 infection altered Graf1 localization from a homogenous distribution within the cytoplasm to granules. Graf1 colocalized with hPIV-2 P, NP, and L proteins. Graf1 interacts with P and V proteins via their N-terminal common region, and the C-terminal Src homology 3 domain-containing region of Graf1 is important for these interactions. In HEK293 cells constitutively expressing Graf1, hPIV-2 growth was inhibited, and RhoA activation was not observed during hPIV-2 infection. In contrast, Graf1 knockdown restored hPIV-2 growth and RhoA activation. Overexpression of hPIV-2 P and V proteins enhanced hPIV-2-induced RhoA activation. These results collectively suggested that hPIV-2 P and V proteins enhanced hPIV-2 growth by binding to Graf1 and that Graf1 inhibits hPIV-2 growth through RhoA inactivation. IMPORTANCE: Robust growth of hPIV-2 requires Rho activation. hPIV-2 infection causes RhoA activation, which is suppressed by Graf1. Graf1 colocalizes with viral RNP (vRNP) in hPIV-2-infected cells. We found that Graf1 interacts with hPIV-2 P and V proteins. We also identified regions in these proteins which are important for this interaction. hPIV-2 P and V proteins enhanced the hPIV-2 growth via binding to Graf1, while Graf1 inhibited hPIV-2 growth through RhoA inactivation.
Copyright © 2016, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27512058      PMCID: PMC5044827          DOI: 10.1128/JVI.01471-16

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  57 in total

Review 1.  Actin and Rho GTPases in herpesvirus biology.

Authors:  Herman W Favoreel; L W Enquist; Becket Feierbach
Journal:  Trends Microbiol       Date:  2007-08-30       Impact factor: 17.079

2.  Pharmacological properties of Y-27632, a specific inhibitor of rho-associated kinases.

Authors:  T Ishizaki; M Uehata; I Tamechika; J Keel; K Nonomura; M Maekawa; S Narumiya
Journal:  Mol Pharmacol       Date:  2000-05       Impact factor: 4.436

3.  Human parainfluenza virus type 2 phosphoprotein: mapping of monoclonal antibody epitopes and location of the multimerization domain.

Authors:  M Nishio; M Tsurudome; M Ito; N Watanabe; M Kawano; H Komada; Y Ito
Journal:  J Gen Virol       Date:  1997-06       Impact factor: 3.891

Review 4.  Signaling role of Cdc42 in regulating mammalian physiology.

Authors:  Jaime Melendez; Matthew Grogg; Yi Zheng
Journal:  J Biol Chem       Date:  2010-11-29       Impact factor: 5.157

5.  The paramyxovirus simian virus 5 V protein slows progression of the cell cycle.

Authors:  G Y Lin; R A Lamb
Journal:  J Virol       Date:  2000-10       Impact factor: 5.103

6.  Mapping of domains on the human parainfluenza type 2 virus P and NP proteins that are involved in the interaction with the L protein.

Authors:  M Nishio; M Tsurudome; M Ito; Y Ito
Journal:  Virology       Date:  2000-08-01       Impact factor: 3.616

7.  High resistance of human parainfluenza type 2 virus protein-expressing cells to the antiviral and anti-cell proliferative activities of alpha/beta interferons: cysteine-rich V-specific domain is required for high resistance to the interferons.

Authors:  M Nishio; M Tsurudome; M Ito; M Kawano; H Komada; Y Ito
Journal:  J Virol       Date:  2001-10       Impact factor: 5.103

8.  Human parainfluenza virus type 2 L protein regions required for interaction with other viral proteins and mRNA capping.

Authors:  Machiko Nishio; Masato Tsurudome; Dominique Garcin; Hiroshi Komada; Morihiro Ito; Philippe Le Mercier; Tetsuya Nosaka; Daniel Kolakofsky
Journal:  J Virol       Date:  2010-11-10       Impact factor: 5.103

9.  The carboxyl segment of the mumps virus V protein associates with Stat proteins in vitro via a tryptophan-rich motif.

Authors:  Machiko Nishio; Dominique Garcin; Viviane Simonet; Daniel Kolakofsky
Journal:  Virology       Date:  2002-08-15       Impact factor: 3.616

10.  A Rac1/Cdc42 GTPase-specific small molecule inhibitor suppresses growth of primary human prostate cancer xenografts and prolongs survival in mice.

Authors:  Karin Zins; Trevor Lucas; Patrick Reichl; Dietmar Abraham; Seyedhossein Aharinejad
Journal:  PLoS One       Date:  2013-09-11       Impact factor: 3.240

View more
  3 in total

1.  Human parainfluenza virus type 2 V protein inhibits induction of tetherin.

Authors:  Keisuke Ohta; Yusuke Matsumoto; Natsuko Yumine; Machiko Nishio
Journal:  Med Microbiol Immunol       Date:  2017-04-28       Impact factor: 3.402

2.  Inhibition of Cavin3 Degradation by the Human Parainfluenza Virus Type 2 V Protein Is Important for Efficient Viral Growth.

Authors:  Keisuke Ohta; Yusuke Matsumoto; Machiko Nishio
Journal:  Front Microbiol       Date:  2020-04-30       Impact factor: 5.640

Review 3.  The role of GTPase-activating protein ARHGAP26 in human cancers.

Authors:  Lingye Zhang; Anni Zhou; Shengtao Zhu; Li Min; Si Liu; Peng Li; Shutian Zhang
Journal:  Mol Cell Biochem       Date:  2021-10-30       Impact factor: 3.396

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.